• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 60 Results
Document Number CR190326
 
 1 
 2 
 3 
 4 
 5 
 6 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K142353 Amphetamines Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K142353 Cannabinoids (THC) Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K151441 Phencyclidine (PCP) Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K142353 Cocaine metabolites Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K151441 Methadone Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K150162 Methamphetamine/amphetamine Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K150162 Benzodiazepines Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K150162 Morphine Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Drug Test Cup  
CR190326 K151441 Oxycodone Toxicology / TDM WAIVED 07/02/2019
Clinical Reference Laboratory, CRLstat Onsite Buprenorphine Drug Test Cup  
CR190326 K152551 Buprenorphine Toxicology / TDM WAIVED 07/02/2019

-
-